A Resource Guide to Investing in Biotechnology
Directory - Encyclopedia - Stock Index - Drugs  

Biotech100 Stock Index

Pain Therapeutics Inc.

About Pain Therapeutics Inc.

Pain Therapeutics is a biopharmaceutical company that develops novel drugs.

Their drugs target severe chronic pain, such as pain associated with advanced osteoarthritis, low-back pain or irritable bowel syndrome.

Pain Therapeutics has three proprietary drug candidates in clinical development: Oxytrex, Remoxy and PTI-901. Pain Therapeutics believe the target market for these three drug candidates exceeds $3 billion per year.




OXYTREX -- treat severe chronic pain, such as low back, osteoarthritic pain or cancer pain

REMOXY --is a proprietary abuse-resistant version of time-release oxycodone

PTI-901 --treats chronic Irritable Bowel Syndrome (IBS). PTI-901 is a proprietary drug candidate that consists of an oral low-dose opioid antagonist



More About Pain Therapeutics

Home Page

Key Statistics for Pain Therapeutics

Basic Chart for Pain Therapeutics

Analyst Opinion

Analysts Estimates


Biotech100 Index
What are the Requirements to be listed in the Biotech100 Index?
See the Biotech100 List

Sponsored Links

Clinical Trials
What is a Clinical Trial?
Phase I ,-- Phase II, -- PhaseIII
What is Randomized Control?
 What is a Double Blind Experiment?
What is the role of the FDA?


Key Biotech Terms


Biotech Resources


Investing in Stocks
Small Cap Stocks
Stocks and Bonds
Biotech100 Index

Careers and Employment
Biotechnology and Pharmaceutical
What are the Fastest Growing Careers?




Copyright 2005 BIOTECH100.COM. All rights reserved.